"Arthritis and Rheumatology, Integrative Health, Regenerative Medicine"

During the past decade, Greater Chicago Specialty Physicians conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Greater Chicago Specialty Physicians" are "Systemic Lupus Erythematosus" (3 trials), "Active Systemic Lupus Erythematosus" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Greater Chicago Specialty Physicians" in a lesser frequency.

Most popular intervention types in "Greater Chicago Specialty Physicians" are "Drug" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Deucravacitinib" (3 trials), "Afimetoran" (1 trials), "Efavaleukin Alfa" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Greater Chicago Specialty Physicians" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Greater Chicago Specialty Physicians". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Greater Chicago Specialty Physicians, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Greater Chicago Specialty Physicians, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".